Indefinite Delivery Contract SPE2DX16D9932
- Not listed
- The Indefinite Delivery Contract (IDC) SPE2DX15D2902 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The single-award IDC, valued at up to $4,999,999.00, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials,...
- The Indefinite Delivery Contract (IDC) SPE2DX16D3924 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The single-award contract, valued at up to $4,999,999.00, runs through November 2023 and covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract includes specialty medications, brand-name and generic drugs,...
- The Indefinite Delivery Contract (IDC) SPE2DX15D5028 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,999,999.00 single-award IDC, with a period of performance through December 31, 2025, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
- The Indefinite Delivery Contract (IDC) SPE2DX16D9945 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The single-award IDC, valued at up to $4,999,999.99, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty...
- The indefinite delivery contract (IDC) SPE2DX15D7050 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The single-award IDC has a ceiling value of $4,999,999.00 and a period of performance through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
- The Indefinite Delivery Contract (IDC) SPE2DX16D2922 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The single-award IDC, valued at up to $4,999,999.99, runs through December 31, 2025 and serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
- The Indefinite Delivery Contract (IDC) SPE2DX15D6910 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The single-award IDC, valued at up to $4,999,999.00, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications,...
- The indefinite delivery contract (IDC) SPE2DX15D7912 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This single-award IDC, valued at up to $4,999,999.00, runs through November 30, 2026 and serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers...
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The single-award IDC, valued at up to $4,999,999.00, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract scope includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits...
- The Indefinite Delivery Contract (IDC) SPE2DX16D3921 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,999,999.00 single-award contract, which runs through November 2023, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses the provision of specialty medications, brand-name and generic...
The indefinite delivery contract (IDC) SPE2DX16D9932 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of parent company Cencora, Inc. This single-award IDC, valued at up to $4,999,999.99, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract includes the provision of specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas such as cardiovascular health, diabetes management, mental health treatments, pain management, infectious disease prevention, and general medical care. This IDC serves as the primary vehicle for the DLA to efficiently procure essential pharmaceutical and medical commodities for military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The period of performance runs through December 31, 2025. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 4/1/16 |